Logo

Roche's Accu-Chek SugarView App Receives CE Mark Approval for Non-Insulin-Dependent Patients with Type 2 Diabetes or Pre-Diabetes

Share this

Roche's Accu-Chek SugarView App Receives CE Mark Approval for Non-Insulin-Dependent Patients with Type 2 Diabetes or Pre-Diabetes

Shots:

  • Roche has received a CE mark for its Accu-Chek SugarView app leading towards the launch of the app in EU and other countries across the globe requiring CE mark. The app is designed to help non-insulin-dependent people with T2D/ pre-diabetes live healthier lives in-between doctors’ visits
  • Roche will enable app initially accessible on certain smartphone model via the Google Play Store- thus enabling broader access to therapy relevant information for diabetic patients
  • Accu-Chek SugarView is an easy-to-use app which bypasses the need for a blood glucose meter as it determines the blood glucose range using the Accu-Chek Active test strip and two photos were taken off the strip with a smartphone camera and algorithm assigns the blood glucose result on the test strip ranging from low to very high

Click here to­ read full press release/ article 

Ref: Roche | Image: Roche 


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions